Differential MicroRNAs Expression in Serum of Patients with Lung Cancer, Pulmonary Tuberculosis, and Pneumonia

Cell Biochemistry and Biophysics

Volumn 67, Issue 3, 2013, Pages 875-884

  Abd El Fattah, Amal A ^a   Sadik, Nermin Abdel Hamid ^a   Shaker, Olfat Gamil ^a   Aboulftouh, Mariam Lotfy ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Lung cancer; miRNA; Pneumonia; Pulmonary tuberculosis

Indexed keywords

BIOLOGICAL MARKER; MICRORNA;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUBERCULOSIS; LUNG TUMOR; MALE; METABOLISM; MIDDLE AGED; PNEUMONIA; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; AREA UNDER CURVE; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; PNEUMONIA; ROC CURVE; TUBERCULOSIS, PULMONARY;

EID: 84888308767     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-013-9575-y     Document Type: Article

References (64)

1. Chen, X., Leung, S. Y., Yuen, S. T., Chu, K. M., Ji, J., Li, R., et al. (2003). Variation in gene expression patterns in human gastric cancers. Molecular Biology of the Cell, 14, 3208-3215.
2. Liu, J., Carmell, M. A., Rivas, F. V., Marsden, C. G., Thomson, J. M., Song, J.-J., et al. (2004). Argonaute2 is the catalytic engine of mammalian RNAi. Science, 305, 1437-1441.
3. Neilson, J. R., & Sharp, P. A. (2008). Small RNA regulators of gene expression. Cell, 134, 899-902.
4. Fabbri, M., Garzon, R., Cimmino, A., Liu, Z., Zanesi, N., Callegari, E., et al. (2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proceedings of the National Academy of Sciences of the United States of America, 104, 15805-15810.
5. Mertens-Talcott, S. U., Chintharlapalli, S., Li, X., & Safe, S. (2007). The oncogenic microRNA-27a targets genes that regulate specificity protein transcription factors and the G2-M checkpoint in MDA-MB-231 breast cancer cells. Cancer Research, 67, 11001-11011.
6. Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 120, 15-20.
7. Calin, G. A., & Croce, C. M. (2006). MicroRNA signatures in human cancers. Nature Reviews Cancer, 6, 857-866.
8. Calin, G. A., & Croce, C. M. (2006). MicroRNA-cancer connection: The beginning of a new tale. Cancer Research, 66, 7390-7394.
9. Esquela-Kerscher, A., & Slack, F. J. (2006). Oncomirs: MicroRNAs with a role in cancer. Nature Reviews Cancer, 6, 259-269.
10. Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., et al. (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-838.
11. Shenouda, S. K., & Alahari, S. K. (2009). MicroRNA function in cancer: Oncogene or a tumor suppressor? Cancer Metastasis Reviews, 28, 369-378.
12. Garofalo, M., Condorelli, G. L., Croce, C. M., & Condorelli, G. (2010). MicroRNAs as regulators of death receptors signaling. Cell Death and Differentiation, 17, 200-208.
13. Kouhkan, F., Alizadeh, S., Kaviani, S., Soleimani, M., Pourfathollah, A. A., Amirizadeh, N., et al. (2011). miR-155 down regulation by LNA inhibitor can reduce cell growth and proliferation in PC12 cell line. Avicenna Journal of Medical Biotechnology, 3, 61-66.
14. Henschke, C. I., & Yankelevitz, D. F. (2008). CT screening for lung cancer: Update 2007. The Oncologist, 13, 65-78.
15. Kuper, H., Adami, H.-O., & Trichopouos, D. (2000). Infections as a major preventable cause of human cancer. Journal of Internal Medicine, 248, 171-183.
16. McCall, C. E., & Yoza, B. K. (2007). Gene silencing in severe systemic inflammation. American Journal of Respiratory and Critical Care Medicine, 175, 763-767.
17. Sonkoly, E., Stahle, M., & Pivarcsi, A. (2008). MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Seminars in Cancer Biology, 18, 131-140.
18. Nana-Sinkam, S. P., Hunter, M. G., Nuovo, G. J., Schmittgen, T. D., Gelinas, R., Galas, D., et al. (2009). Integrating the MicroRNome into the study of lung disease. American Journal of Respiratory and Critical Care Medicine, 179, 4-10.
19. O'Connell, R. M., Rao, D. S., Chaudhuri, A. A., & Baltimore, D. (2010). Physiological and pathological roles for microRNAs in the immune system. Nature Reviews Immunology, 10, 111-122.
20. Dye, C., & Williams, B. G. (2010). The population dynamics and control of tuberculosis. Science, 328, 856-861.
21. Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., et al. (2008). Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research, 18, 997-1006.
22. Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., et al. (2008). Circulating microRNAs as stable blood-based markers for cancer detection. Proceedings of the National Academy of Sciences of the United States of America, 105, 10513-10518.
23. McDonald, J. S., Milosevic, D., Reddi, H. V., Grebe, S. K., & Algeciras-Schimnich, A. (2011). Analysis of circulating microRNA: Preanalytical and analytical challenges. Clinical Chemistry, 57, 833-840.
24. Arroyo, J. D., Chevillet, J. R., Kroh, E. M., Ruf, I. K., Pritchard, C. C., Gibson, D. F., et al. (2011). Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America, 108, 5003-5008.
25. Yanaihara, N., Caplen, N., Bowman, E., Seike, M., Kumamoto, K., Yi, M., et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell, 9, 189-198.
26. Zhao, H., Shen, J., Medico, L., Wang, D., Ambrosone, C. B., & Liu, S. (2010). A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One, 5(10), e13735.
27. Heegaard, N. H. H., Schetter, A. J., Welsh, J. A., Yoneda, M., Bowman, E. D., & Harris, C. C. (2012). Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. International Journal of Cancer, 130, 1378-1386.
28. Light, R. W., MacGregor, M. I., Luchsinger, P. C., & Ball, C. W. (1972). Pleural effusions: The diagnostic separation of transudates and exudates. Annals of Internal Medicine, 77, 507-513.
29. Light, R. W. (1983). Pleural diseases. Philadelphia, PA: Lea and Febiger.
30. Guisti, G. (1974). Adenosine deaminase. In: H. V. Bergmeyer (Ed), Methods of enzymatic analysis (pp. 1092-1099). New York, NY: Academic Press.
31. Barshack, I., Lithwick-Yanai, G., Afek, A., Rosenblatt, K., Tabibian-Keissar, H., Zepeniuk, M., et al. (2010). MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathology, Research and Practice, 206, 578-584.
32. Livak, K. J., & Schmittgen, T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods, 25, 402-408.
33. Shen, J., Todd, N. W., Zhang, H., Yu, L., Lingxiao, X., Mei, Y., et al. (2011). Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Laboratory investigation; A Journal of Technical Methods and Pathology, 91, 579-587.
34. Wang, F., Zheng, Z., Guo, J., & Ding, X. (2010). Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecologic Oncology, 119, 586-593.
35. Gallo, A., Tandon, M., Alevizos, I., & Illei, G. G. (2012). The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One, 7, e30679.
36. Valadi, H., Ekstrom, K., Bossios, A., Sjostrand, M., Lee, J. J., & Lotvall, J. O. (2007). Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nature Cell Biology, 9, 654-659.
37. Kosaka, N., Iguchi, H., Yoshioka, Y., Takeshita, F., Matsuki, Y., & Ochiya, T. (2010). Secretory mechanisms and intercellular transfer of microRNAs in living cells. The Journal of biological chemistry, 285, 17442-17452.
38. Taylor, D. D., & Gercel-Taylor, C. (2008). MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecologic Oncology, 110, 13-21.
39. Kong, W. (2010). The Role of microRNA-155 in human breast cancer. Graduate School Theses and Dissertations, South Florida. http://scholarcommons. usf. edu/etd/3647.
40. Jiang, S., Zhang, H. W., Lu, M. H., He, X. H., Li, Y., Gu, H., et al. (2010). MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Research, 70, 3119-3127.
41. Markou, A., Tsaroucha, E. G., Kaklamanis, L., Fotinou, M., Georgoulias, V., & Lianidou, E. S. (2008). Prognostic value of mature microRNA-21 and microRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clinical Chemistry, 54, 1696-1704.
42. Zhu, S., Wu, H., Wu, F., Nie, D., Sheng, S., & Mo, Y. Y. (2008). MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Research, 18, 350-359.
43. Iliopoulos, D., Jaeger, S. A., Hirsch, H. A., Bulyk, M. L., & Struhl, K. (2010). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Molecular Cell, 39, 493-506.
44. Meng, F., Henson, R., Wehbe-Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007). MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology, 133, 647-658.
45. Frankel, L. B., Christoffersen, N. R., Jacobsen, A., Lindow, M., Krogh, A., & Lund, A. H. (2008). Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. The Journal of biological chemistry, 283, 1026-1033.
46. Wang, K., Zhang, S., Weber, J., Baxter, D., & Galas, D. J. (2010). Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Research, 38, 7248-7259.
47. Volinia, S., Calin, G. A., Liu, C. G., Ambs, S., Cimmino, A., Petrocca, F., et al. (2006). A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America, 103, 2257-2261.
48. Yu, S. L., Chen, H. Y., Chang, G. C., Chen, C. Y., Chen, H. W., Singh, S., et al. (2008). MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell, 13, 48-57.
49. Zheng, D., Haddadin, S., Wang, Y., Gu, L.-Q., Perry, M. C., Freter, C. E. X., et al. (2011). Plasma microRNAs as novel biomarkers for early detection of lung cancer. International Journal of Clinical and Experimental Pathology, 4, 575-586.
50. Zhang, L., Volinia, S., Bonome, T., Calin, G. A., Greshock, J., Yang, N., et al. (2008). Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America, 105, 7004-7009.
51. Sun, Y., Fang, R., Li, C., Li, L., Li, F., Ye, X., et al. (2010). Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro. Biochemical and Biophysical Research Communications, 396, 501-507.
52. Kong, W.-Q., Bai, R., Liu, T., Cai, C.-L., Liu, M., Li, X., et al. (2012). MicroRNA-182 targets cAMP-responsive element-binding protein 1 and suppresses cell growth in human gastric adenocarcinoma. FEBS Journal, 279(7), 1252-1260.
53. Schulte, L. N., Eulalio, A., Mollenkopf, H. J., Reinhardt, R., & Vogel, J. (2011). Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family. The EMBO Journal, 30, 1977-1989.
54. Moschos, S. A., Williams, A. E., Perry, M. M., Birrell, M. A., Belvisi, M. G., & Lindsay, M. A. (2007). Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics, 8, 240.
55. Liew, F. Y., Xu, D., Brint, E. K., & O'Neill, L. A. J. (2005). Negative regulation of toll-like receptor-mediated immune responses. Nature Reviews Immunology, 5, 446-458.
56. Gilroy, D. W., Lawrence, T., Perretti, M., & Rossi, A. G. (2004). Inflammatory resolution: New opportunities for drug discovery. Nature Reviews Drug Discovery, 3, 401-416.
57. Taganov, K. D., Boldin, M. P., Chang, K. J., & Baltimore, D. (2006). NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proceedings of the National Academy of Sciences of the United States of America, 103, 12481-12486.
58. O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proceedings of the National Academy of Sciences of the United States of America, 104, 1604-1609.
59. Rodriguez, A., Vigorito, E., Clare, S., Warren, M. V., Couttet, P., Soond, D. R., et al. (2007). Requirement of bic/microRNA-155 for normal immune function. Science, 316, 608-611.
60. Banerjee, A., Schambach, F., DeJong, C. S., Hammond, S. M., & Reiner, S. L. (2010). Micro-RNA-155 inhibits IFN-gamma signaling in CD4+ T cells. European Journal of Immunology, 40, 225-231.
61. Yin, Q., McBride, J., Fewell, C., Lacey, M., Wang, X., Lin, Z., et al. (2008). MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. Journal of Virology, 82, 5295-5306.
62. Lu, T. X., Munitz, A., & Rothenberg, M. E. (2009). MicroRNA-21 is up-regulated in allergic airway inflammation and regulates IL-12p35 expression. Journal of Immunology, 182, 4994-5002.
63. Wu, Z., Lu, H., Sheng, J., & Li, L. (2012). Inductive microRNA-21 impairs anti-mycobacterial responses by targeting IL-12 and Bcl-2. FEBS Letters, 586, 2459-2467.
64. Liu, F., Yin, L., Zhang, L., Liu, W., Liu, J., Wang, Y., et al. (2012). Trimetazidine improves right ventricular function by increasing miR-21 expression. International Journal of Molecular Medicine, 30, 849-855.